Leadership Overview
Precision Medicine Group has 9 executives leading key functions including strategy, clinical research, technology, financial operations, and human capital management.
Focused on accelerating drug development and commercialization, Precision Medicine Group delivers specialized life sciences services to global pharmaceutical and biotech clients through integrated research and market access platforms.
Focused on accelerating drug development and commercialization, Precision Medicine Group delivers specialized life sciences services to global pharmaceutical and biotech clients through integrated research and market access platforms.
Leadership Roles at Precision Medicine Group
Margaret Keegan - Chief Executive Officer
Margaret Keegan, the Chief Executive Officer at Precision Medicine Group, directs the overarching corporate strategy and global operational vision. Keegan oversees the integration of clinical research and laboratory services to ensure seamless drug development support for pharmaceutical clients. By aligning internal resources with evolving biotech market demands, the Chief Executive Officer drives sustainable growth across North America, Europe, and Asia-Pacific. This leadership role involves constant collaboration with the board to refine service delivery models and expand the company's footprint in complex therapeutic areas. Margaret Keegan maintains a focus on operational excellence, ensuring that every project meets rigorous quality standards while accelerating time-to-market for critical medical innovations. Through strategic oversight of the entire organization, the Chief Executive Officer fosters a culture of scientific precision and client-centric service, ultimately positioning the firm as a premier partner in the global life sciences ecosystem.

Mark Clein - Co-Founder & Chief Executive Officer
Mark Clein, the Co-Founder & Chief Executive Officer at Precision Medicine Group, architects the long-term vision and foundational business model of the organization. Clein focuses on identifying emerging opportunities within the drug development landscape, guiding the company through complex commercialization challenges. As a primary architect of the firm's dual-platform strategy, the Co-Founder & Chief Executive Officer ensures that Precision for Medicine and Precision AQ remain at the forefront of industry innovation. Mark Clein manages high-level partnerships and investor relations, securing the capital and strategic alignment necessary for international expansion. By fostering a deep commitment to scientific rigor and data-driven insights, the Co-Founder & Chief Executive Officer empowers teams to solve intricate challenges for biotech clients. This leadership role demands constant vigilance regarding market shifts, ensuring the company maintains a competitive edge while delivering transformative solutions that improve patient outcomes across diverse global markets.
Wendy Shusko - Chief Financial Officer, Precision AQ
Wendy Shusko, the Chief Financial Officer, Precision AQ at Precision Medicine Group, manages the financial health and fiscal strategy for the market access and medical communications division. Shusko oversees budgeting, financial reporting, and resource allocation to ensure the profitability of commercialization services. By analyzing payer insights and market trends, the Chief Financial Officer, Precision AQ supports strategic decision-making regarding service expansion and client acquisition. Wendy Shusko collaborates with executive leadership to align financial goals with the broader corporate mission of delivering value to biotech partners. This leadership role involves monitoring operational costs across regional offices to maintain efficiency while scaling service delivery. Through rigorous financial oversight and performance tracking, the Chief Financial Officer, Precision AQ ensures that the division remains a robust contributor to the company's overall revenue growth. Shusko drives fiscal discipline, enabling the firm to invest in the talent and tools required for long-term success.
Mike Winston - Translational Sciences Chief Operating Officer & Chief Financial Officer
Mike Winston, the Translational Sciences Chief Operating Officer & Chief Financial Officer at Precision Medicine Group, directs the financial and operational framework for the translational sciences division. Winston oversees the integration of laboratory services and clinical data, ensuring that scientific research translates effectively into actionable drug development insights. By managing the division's budget and operational capacity, the Translational Sciences Chief Operating Officer & Chief Financial Officer supports the delivery of high-quality genomics and data science services. Mike Winston collaborates with research teams to optimize project timelines and resource utilization, directly impacting the speed of client programs. This leadership role involves balancing scientific innovation with fiscal responsibility to maintain the division's competitive market position. Through the strategic oversight of translational operations, the Translational Sciences Chief Operating Officer & Chief Financial Officer ensures that the firm provides unparalleled value to biotech partners, driving growth through scientific excellence and financial stability.
Chad Clark - President & Chief Operating Officer
Chad Clark, the President & Chief Operating Officer at Precision Medicine Group, executes the daily operational strategy and manages the integration of service delivery across all business units. Clark oversees the internal processes that support clinical research and commercialization, ensuring that project teams meet client milestones with precision. By streamlining workflows and enhancing cross-departmental communication, the President & Chief Operating Officer drives operational efficiency on a global scale. Chad Clark collaborates with other C-suite leaders to implement scalable systems that accommodate the company's rapid growth in North America and beyond. This leadership role involves monitoring key performance indicators to ensure that service quality remains consistent across diverse therapeutic areas. Through the active management of operational resources, the President & Chief Operating Officer supports the firm's commitment to excellence in drug development. Clark ensures that the organization remains agile, responsive, and capable of delivering complex solutions to pharmaceutical clients.

Othniel Badea - Chief Technology Officer
Othniel Badea, the Chief Technology Officer at Precision Medicine Group, directs the development and implementation of advanced digital infrastructure supporting clinical research and data science. Badea oversees the deployment of proprietary software tools that enable precise genomic analysis and laboratory data management. By architecting scalable cloud solutions, the Chief Technology Officer ensures that global teams access real-time insights to accelerate drug development timelines. Othniel Badea collaborates with cross-functional leaders to integrate emerging technologies into existing service platforms, enhancing the efficiency of clinical trials. This leadership role involves managing cybersecurity protocols and data integrity standards across all international operations. Through the continuous optimization of technical workflows, the Chief Technology Officer supports the firm's mission to provide high-fidelity data to pharmaceutical clients. Badea drives innovation in digital health, ensuring that the company remains a leader in leveraging technology to solve complex biological and medical challenges.
Tracey Leahy - Chief People Officer
Tracey Leahy, the Chief People Officer at Precision Medicine Group, directs the global human capital strategy, including talent acquisition, employee development, and organizational culture. Leahy oversees the recruitment of top-tier scientific and commercial talent to support the company's diverse service platforms. By implementing comprehensive training programs and performance management systems, the Chief People Officer ensures that the workforce remains aligned with the firm's mission of accelerating drug development. Tracey Leahy collaborates with executive leadership to foster an inclusive environment that attracts and retains experts across North America, Europe, and Asia-Pacific. This leadership role involves managing compensation structures and employee engagement initiatives to drive productivity and retention. Through the strategic development of the company's human capital, the Chief People Officer supports the firm's ability to deliver complex services to pharmaceutical clients. Leahy drives organizational health, ensuring that the team possesses the expertise required to navigate the evolving life sciences landscape.

David Winn - Chief Administrative Officer, Clinical Solutions
David Winn, the Chief Administrative Officer, Clinical Solutions at Precision Medicine Group, directs the administrative functions and operational support for the clinical research division. Winn oversees the logistical coordination of clinical trials, ensuring that all administrative processes align with regulatory requirements and project timelines. By managing internal support services and facility operations, the Chief Administrative Officer, Clinical Solutions enables research teams to focus on delivering high-quality data to biotech clients. David Winn collaborates with operational leaders to refine administrative workflows, increasing the efficiency of clinical service delivery across global regions. This leadership role involves overseeing compliance protocols and resource management to ensure that the division operates smoothly and effectively. Through the strategic management of administrative operations, the Chief Administrative Officer, Clinical Solutions supports the firm's commitment to excellence in drug development. Winn drives operational stability, ensuring that the clinical solutions platform remains a reliable partner for pharmaceutical innovation.
Eric Hodgins - Chief Information & Technology Officer
Eric Hodgins, the Chief Information & Technology Officer at Precision Medicine Group, directs the enterprise-wide information systems and technological innovation strategy. Hodgins oversees the architecture of secure data platforms that facilitate collaboration between clinical research teams and pharmaceutical clients. By implementing advanced analytics and digital tools, the Chief Information & Technology Officer enhances the firm's ability to process complex genomic and clinical data. Eric Hodgins collaborates with the technology department to ensure that all systems comply with global regulatory standards while supporting rapid service delivery. This leadership role involves managing the company's digital transformation roadmap, ensuring that infrastructure scales alongside business growth. Through the strategic oversight of information technology, the Chief Information & Technology Officer supports the firm's mission to provide data-driven solutions for drug development. Hodgins drives technological advancement, ensuring that the organization remains at the cutting edge of digital health and life sciences service delivery.

Explore Leadership Teams in Advertising Networks
LLYC is a global marketing and corporate affairs consultancy that partners with organizations to enhance and protect business value through strategic communication, creativity, and influence. The company focuses on helping brands build strong reputations, engage effectively with stakeholders, and navigate complex corporate and public environments. By combining expertise in marketing, corporate communications, and public affairs, LLYC supports businesses in strengthening their positioning and achieving sustainable growth in competitive markets.
Company Leadership AS


HH Global is a global creative production and procurement partner that leverages technology to drive sustainable growth for brands. They offer a range of services including creative and digital solutions, procurement, and logistics, with a focus on reducing waste and enhancing efficiency. Their clients include major brands like HSBC, Coca-Cola, and adidas, who seek to improve their marketing effectiveness and sustainability. With a presence in over 120 countries and a commitment to innovation, HH Global aims to deliver impactful solutions tailored to their clients' needs.
Company Leadership LE
AF
JW
Augeo is an engagement company that utilizes its agentic AI, THEO, to enhance loyalty and engagement for a diverse range of clients including employees, customers, attendees, and creators. The company offers solutions such as Augeo Workplace, Augeo Experience, and Augeo Rewards, focusing on personalized engagement strategies that leverage behavioral signals. Augeo also operates a Loyalty Media Network, transforming loyalty programs into revenue-generating media channels for program owners and brand partners. With a strong track record of trust and innovation, Augeo serves nearly 100 Fortune 500 clients across over 20 industries worldwide.
Company Leadership

SI

Golin Ketchum is a global public relations agency formed from the merger of Golin and Ketchum, specializing in healthcare, consumer, corporate affairs, and technology. The agency is recognized for creating impactful change that earns attention and shapes culture for its clients. With a strong focus on brand and consumer engagement, corporate affairs, and health and technology sectors, Golin Ketchum aims to build business through strategic communication. It is noted as the most awarded public relations agency of the decade.
Company Leadership TN
CB
EM
MR